BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ma L, Chua MS, Andrisani O, So S. Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives. World J Gastroenterol 2014; 20(2): 333-345 [PMID: 24574704 DOI: 10.3748/wjg.v20.i2.333]
URL: https://www.wjgnet.com/1007-9327/full/v20/i2/333.htm
Number Citing Articles
1
Braira Wahid, Amjad Ali, Shazia Rafique, Muhammad Idrees. New Insights into the Epigenetics of Hepatocellular CarcinomaBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/1609575
2
Hong-ye Jiang, Gang Ning, Yen-sheng Wang, Wei-biao Lv. 14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma PatientsBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9762067
3
Mai Thanh Binh, Nghiem Xuan Hoan, Dao Phuong Giang, Hoang Van Tong, C.-Thomas Bock, Heiner Wedemeyer, Nguyen Linh Toan, Mai Hong Bang, Peter G. Kremsner, Christian G. Meyer, Le Huu Song, Thirumalaisamy P. Velavan. Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinomaScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59667-z
4
Monica Valente, Alessia Covre, Anna Maria Di Giacomo, Michele Maio. Hepato-Pancreato-Biliary Malignancies2022; : 761 doi: 10.1007/978-3-030-41683-6_50
5
Xian Qin, Jing Chen, Long Wu, Zhisu Liu. MiR-30b-5p acts as a tumor suppressor, repressing cell proliferation and cell cycle in human hepatocellular carcinomaBiomedicine & Pharmacotherapy 2017; 89: 742 doi: 10.1016/j.biopha.2017.02.062
6
Mohamed H. Yousef, Hassan A. N. El-Fawal, Anwar Abdelnaser, Junyan Tao. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular CarcinomaBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9593254
7
YUJI INAGAKI, KATSUYA SHIRAKI, KAZUSHI SUGIMOTO, TAKAZUMI YADA, MASAHIKO TAMEDA, SUGURU OGURA, NORIHIKO YAMAMOTO, YOSHIYUKI TAKEI, MASAAKI ITO. Epigenetic regulation of proliferation and invasion in hepatocellular carcinoma cells by CBP/p300 histone acetyltransferase activityInternational Journal of Oncology 2016; 48(2): 533 doi: 10.3892/ijo.2015.3288
8
XIAOJIAO ZHANG, JUN ZHANG, RUI WANG, SHICHENG GUO, HUILU ZHANG, YANYUN MA, QINGMEI LIU, HAIYAN CHU, XIANGHONG XU, YITONG ZHANG, DONGQIN YANG, JIUCUN WANG, JIE LIU. Hypermethylation reduces the expression of PNPLA7 in hepatocellular carcinomaOncology Letters 2016; 12(1): 670 doi: 10.3892/ol.2016.4660
9
Matthew Hoare. Liver Cancers2019; : 39 doi: 10.1007/978-3-319-92216-4_4
10
Hongye Jiang, Gang Ning, Yensheng Wang, Weibiao Lv, Andrea Maugeri. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment ResponseDisease Markers 2021; 2021: 1 doi: 10.1155/2021/5576683
11
Sathish Kumar Mungamuri, Vijay Aditya Mavuduru. Role of epigenetic alterations in aflatoxin‐induced hepatocellular carcinomaLiver Cancer International 2020; 1(2): 41 doi: 10.1002/lci2.20
12
Silvia Udali, Patrizia Guarini, Sara Moruzzi, Andrea Ruzzenente, Stephanie A. Tammen, Alfredo Guglielmi, Simone Conci, Patrizia Pattini, Oliviero Olivieri, Roberto Corrocher, Sang‐Woon Choi, Simonetta Friso. Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rateHepatology 2015; 62(2): 496 doi: 10.1002/hep.27823
13
Sahar Olsadat Sajadian, Chaturvedula Tripura, Fazel Sahraneshin Samani, Marc Ruoss, Steven Dooley, Hossein Baharvand, Andreas K. Nussler. Vitamin C enhances epigenetic modifications induced by 5-azacytidine and cell cycle arrest in the hepatocellular carcinoma cell lines HLE and Huh7Clinical Epigenetics 2016; 8(1) doi: 10.1186/s13148-016-0213-6
14
J. Tajbakhsh, J. Singh. Medical Epigenetics2016; : 555 doi: 10.1016/B978-0-12-803239-8.00031-4
15
Dan-Dan Wan, Xiao-Ju Li, Xing-Ru Wang, Tian-Xi Liu. Metachronous multifocal carcinoma: A case reportWorld Journal of Gastrointestinal Oncology 2024; 16(7): 3350-3356 doi: 10.4251/wjgo.v16.i7.3350
16
Bin-yong Liang, Min Xiong, Gui-bao Ji, Er-lei Zhang, Zun-yi Zhang, Ke-shuai Dong, Xiao-ping Chen, Zhi-yong Huang. Synergistic suppressive effect of PARP-1 inhibitor PJ34 and HDAC inhibitor SAHA on proliferation of liver cancer cellsJournal of Huazhong University of Science and Technology [Medical Sciences] 2015; 35(4): 535 doi: 10.1007/s11596-015-1466-6
17
Saleh Daher, Muhammad Massarwa, Ariel A. Benson, Tawfik Khoury. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive ReviewJournal of Clinical and Translational Hepatology 2018; 6(1): 1 doi: 10.14218/JCTH.2017.00031
18
Dan Wang, Chendong Yang, Zhuien Wang, Yi Yang, Defang Li, Xiaojie Ding, Wenjuan Xu, Qiusheng Zheng. RETRACTED ARTICLE: Norcantharidin combined with Coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulationScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09668-2
19
Jun Zhao, Steven G. Gray, Martin Wabitsch, Catherine M. Greene, Matthew W. Lawless. The therapeutic properties of resminostat for hepatocellular carcinomaOncoscience 2018; 5(5-6): 196 doi: 10.18632/oncoscience.420
20
Jose Arriola-Montenegro, Renato Beas, Renato Cerna-Viacava, Andres Chaponan-Lavalle, Karla Hernandez Randich, Diego Chambergo-Michilot, Herson Flores Sanga, Pornthira Mutirangura. Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver diseaseWorld Journal of Cardiology 2023; 15(7): 328-341 doi: 10.4330/wjc.v15.i7.328
21
Renato Heidor, Ernesto Vargas-Mendez, Fernando Salvador Moreno. Epigenetics of Cancer Prevention2019; : 231 doi: 10.1016/B978-0-12-812494-9.00011-1
22
Mina S. Makary, Umang Khandpur, Jordan M. Cloyd, Khalid Mumtaz, Joshua D. Dowell. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management StrategiesCancers 2020; 12(7): 1914 doi: 10.3390/cancers12071914
23
Hao Liang, Mingxing Xu, Zhiyong Xiong, Kunpeng Hu, Jiarui Yang, Mingbo Cao, Zhaozhong Zhong, Zhicheng Yao, Meihai Deng, Bo Liu. Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinomaAging 2021; 13(4): 6115 doi: 10.18632/aging.202606
24
Luca Sanna, Irene Marchesi, Mariarosa A. B. Melone, Luigi Bagella. The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinomaJournal of Cellular Physiology 2018; 233(9): 6508 doi: 10.1002/jcp.26545
25
Surya Sukumaran, Mingdian Tan, Shulamit Fluss Ben-Uliel, Hui Zhang, Marta De Zotti, Mei-Sze Chua, Samuel K. So, Nir Qvit. Rational design, synthesis and structural characterization of peptides and peptidomimetics to target Hsp90/Cdc37 interaction for treating hepatocellular carcinomaComputational and Structural Biotechnology Journal 2023; 21: 3159 doi: 10.1016/j.csbj.2023.05.023
26
Jingting Kang, Jie Wang, Jin Cheng, Zhiliang Cao, Ran Chen, Huiyu Li, Shuang Liu, Xiangmei Chen, Jianhua Sui, Fengmin Lu. Down-regulation of NTCP expression by cyclin D1 in hepatitis B virus-related hepatocellular carcinoma has clinical significanceOncotarget 2017; 8(34): 56041 doi: 10.18632/oncotarget.10241
27
Ke Shi, Jie Hou, Qun Zhang, Yufei Bi, Xuanwei Zeng, Xianbo Wang. Neutrophil-to-high-density-lipoprotein-cholesterol ratio and mortality among patients with hepatocellular carcinomaFrontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1127913
28
Gang Ning, Yan-Lin Huang, Li-Min Zhen, Wen-Xiong Xu, Qian Jiao, Fang-Ji Yang, Li-Na Wu, Yong-Yuan Zheng, Jie Song, Yen-Sheng Wang, Chan Xie, Liang Peng. Transcriptional expressions of Chromobox 1/2/3/6/8 as independent indicators for survivals in hepatocellular carcinoma patientsAging 2018; 10(11): 3450 doi: 10.18632/aging.101658
29
Aya El Khodiry, Menna Afify, Hend M El Tayebi. Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesisWorld Journal of Gastroenterology 2018; 24(5): 549-572 doi: 10.3748/wjg.v24.i5.549
30
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infectionWorld Journal of Hepatology 2017; 9(36): 1305-1314 doi: 10.4254/wjh.v9.i36.1305
31
Gislaine Dionísio Ferreira, Glaucia Maria de Mendonça Fernandes, Camila Penteado, Vivian Romanholi Cória, Ana Lívia da Silva Galbiatti-Dias, Anelise Russo, Márcia Maria Urbanin Castanhole-Nunes, Renato Ferreira da Silva, Rita de Cássia Martins Alves da Silva, Érika Cristina Pavarino, Mariangela Torreglosa Ruiz Cintra, Eny Maria Goloni-Bertollo. Polymorphisms in xenobiotic metabolism-related genes in patients with hepatocellular carcinoma: a case–control studyXenobiotica 2021; 51(6): 737 doi: 10.1080/00498254.2021.1893408
32
Jin Sun, Beibei Bie, Shu Zhang, Jun Yang, Zongfang Li. Long Non-Coding RNAs: Critical Players in Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2014; 15(11): 20434 doi: 10.3390/ijms151120434
33
Yong-Ru Liu, Rui-Xue Tang, Wen-Ting Huang, Fang-Hui Ren, Rong-Quan He, Li-Hua Yang, Dian-Zhong Luo, Yi-Wu Dang, Gang Chen. Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanismWorld Journal of Hepatology 2015; 7(28): 2781-2791 doi: 10.4254/wjh.v7.i28.2781
34
Venkat Bhat, Sujitha Srinathan, Elisa Pasini, Marc Angeli, Emily Chen, Cristina Baciu, Mamatha Bhat. Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysisWorld Journal of Hepatology 2018; 10(1): 155-165 doi: 10.4254/wjh.v10.i1.155
35
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Zeinab Ahsani, Mahdi Paryan. Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinomaTumor Biology 2017; 39(4): 101042831769836 doi: 10.1177/1010428317698361
36
Xiaopeng Cai, Jiaming Zhou, Jingwen Deng, Zhi Chen. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinomaCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02413-w
37
T. Vescovo, G. Refolo, G. Vitagliano, G.M. Fimia, M. Piacentini. Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinomaClinical Microbiology and Infection 2016; 22(10): 853 doi: 10.1016/j.cmi.2016.07.019
38
Roseane Guimarães Ferreira, Magda Vieira Cardoso, Karine Maria de Souza Furtado, Kaio Murilo Monteiro Espíndola, Ruanderson Pereira Amorim, Marta Chagas Monteiro. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinomaTranslational Research 2019; 204: 51 doi: 10.1016/j.trsl.2018.09.001
39
Ahmed H. F. El-Tawdi, Marwa Matboli, Sarah El-Nakeep, Ahmed E. M. Azazy, Omar Abdel-Rahman. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2016; 10(7): 869 doi: 10.1080/17474124.2016.1193003
40
Diagnostic Pathology: Molecular Oncology2016; : 8-104 doi: 10.1016/B978-0-323-37678-5.50142-0
41
Xinye Qian, Zhoujing Yang, Lu Gao, Yipiao Liu, Jun Yan. The role of complement in the clinical course of hepatocellular carcinomaImmunity, Inflammation and Disease 2022; 10(3) doi: 10.1002/iid3.569
42
M.G. Fernandez-Barrena, C.L. Pin. Chromatin Signaling and Diseases2016; : 365 doi: 10.1016/B978-0-12-802389-1.00020-4
43
Kaveri Sidhu, Neetu Rohit Kapoor, Vijaya Pandey, Vijay Kumar. The “Macro” World of microRNAs in Hepatocellular CarcinomaFrontiers in Oncology 2015; 5 doi: 10.3389/fonc.2015.00068
44
Didier Meseure, Kinan Drak Alsibai, Andre Nicolas, Ivan Bieche, Antonin Morillon. Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic TargetsBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/320214
45
Xuefeng Kan, Wanli Zhang, Ruxu You, Yanfeng Niu, Jianrong Guo, Jun Xue. Scutellaria barbata D. Don extract inhibits the tumor growth through down-regulating of Treg cells and manipulating Th1/Th17 immune response in hepatoma H22-bearing miceBMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-016-1551-9
46
Jun Zhao, Steven G. Gray, Catherine M. Greene, Matthew W. Lawless. Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancerExpert Review of Gastroenterology & Hepatology 2019; 13(3): 247 doi: 10.1080/17474124.2019.1568870
47
Verona Buocikova, Ivan Rios-Mondragon, Eleftherios Pilalis, Aristotelis Chatziioannou, Svetlana Miklikova, Michal Mego, Karlis Pajuste, Martins Rucins, Naouale El Yamani, Eleonora Marta Longhin, Arkadij Sobolev, Muriel Freixanet, Victor Puntes, Aiva Plotniece, Maria Dusinska, Mihaela Roxana Cimpan, Alena Gabelova, Bozena Smolkova. Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine PerspectivesCancers 2020; 12(12): 3622 doi: 10.3390/cancers12123622
48
Shahrzad Movafagh, Amanda Munson. Epigenetics of Cancer Prevention2019; : 75 doi: 10.1016/B978-0-12-812494-9.00004-4
49
R. Heidor, J. M. Affonso, T. P. Ong, F. S. Moreno. Nutrition and Cancer Prevention2019; : 339 doi: 10.1039/9781788016506-00339
50
Smriti Verma, Bidya Dhar Sahu, Madhav Nilakanth Mugale. Role of lncRNAs in hepatocellular carcinomaLife Sciences 2023; 325: 121751 doi: 10.1016/j.lfs.2023.121751
51
Yi-Ru Chen, Su-Shan Ouyang, Yan-Ling Chen, Ping Li, Hui-Wen Xu, Sen-Lin Zhu. BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinomaAging 2020; 12(17): 17541 doi: 10.18632/aging.103768
52
Yi-Gang Wang, Pan-Pan Huang, Rong Zhang, Bu-Yun Ma, Xiu-Mei Zhou, Yan-Fang Sun. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(1): 326-337 doi: 10.3748/wjg.v22.i1.326
53
Desirée Bartolini, Katiuscia Dallaglio, Pierangelo Torquato, Marta Piroddi, Francesco Galli. Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinomaTranslational Research 2018; 193: 54 doi: 10.1016/j.trsl.2017.11.007
54
Thomas Couri, Anjana Pillai. Goals and targets for personalized therapy for HCCHepatology International 2019; 13(2): 125 doi: 10.1007/s12072-018-9919-1
55
Ke Shi, Yufei Bi, Xuanwei Zeng, Xianbo Wang. Effects of adjuvant huaier granule therapy on survival rate of patients with hepatocellular carcinomaFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1163304
56
Zhenjing Shi, Ya Luo, Minghui Zhu, Yu Zhou, Bingru Zheng, Daoyi Wu, Shuting Wang, Xiangbang Xie, Heping Lin, Xixiang Yu. Expression Analysis of Long Non-Coding RNA HAR1A and HAR1B in HBV-Induced Hepatocullular Carcinoma in Chinese PatientsLaboratory Medicine 2019; 50(2): 150 doi: 10.1093/labmed/lmy055
57
Chit Tam, Jack Ho Wong, Stephen Kwok Wing Tsui, Tao Zuo, Ting Fung Chan, Tzi Bun Ng. LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent yearsApplied Microbiology and Biotechnology 2019; 103(12): 4649 doi: 10.1007/s00253-019-09837-5
58
Ioannis Anestopoulos, Georgia Persephoni Voulgaridou, Alexandros G. Georgakilas, Rodrigo Franco, Aglaia Pappa, Mihalis I. Panayiotidis. Epigenetic therapy as a novel approach in hepatocellular carcinomaPharmacology & Therapeutics 2015; 145: 103 doi: 10.1016/j.pharmthera.2014.09.005
59
Q Xu, F Deng, Y Qin, Z Zhao, Z Wu, Z Xing, A Ji, Q J Wang. Long non-coding RNA regulation of epithelial–mesenchymal transition in cancer metastasisCell Death & Disease 2016; 7(6): e2254 doi: 10.1038/cddis.2016.149
60
Jie Li, Mengxi Liu. Aflatoxin B1 Occurrence, Detection and Toxicological Effects2020;  doi: 10.5772/intechopen.88353
61
Adane Adugna. Histomolecular characterisation of hepatitis B virus induced liver cancerReviews in Medical Virology 2023; 33(6) doi: 10.1002/rmv.2485
62
Shan Lu, Ziqi Meng, Yingying Tan, Chao Wu, Zhihong Huang, Jiaqi Huang, Changgeng Fu, Antony Stalin, Siyu Guo, Xinkui Liu, Leiming You, Xiaojiaoyang Li, Jingyuan Zhang, Wei Zhou, Xiaomeng Zhang, Miaomiao Wang, Jiarui Wu. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verificationBMC Complementary Medicine and Therapies 2022; 22(1) doi: 10.1186/s12906-022-03530-3
63
Sheng-xian Yuan, Jin Zhang, Qing-guo Xu, Yuan Yang, Wei-ping Zhou. Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinomaCancer Letters 2016; 379(2): 239 doi: 10.1016/j.canlet.2015.08.008
64
Hye Seung Lee, Wonkyung Jung, Eunjung Lee, Hyeyoon Chang, Jin Hyuk Choi, Han Gyeom Kim, Aeree Kim, Baek-hui Kim. SIRT7, H3K18ac, and ELK4 Immunohistochemical Expression in Hepatocellular CarcinomaJournal of Pathology and Translational Medicine 2016; 50(5): 337 doi: 10.4132/jptm.2016.05.20
65
Bingxin Lei, Hongxiao Song, Fengchao Xu, Qi Wei, Fei Wang, Guangyun Tan, Haichun Ma. When does hepatitis B virus meet long-stranded noncoding RNAs?Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.962186
66
Aiyao Wang, Jun Meng, Hui Liu, Chen Li, Zhiyong Zhou. Long non‑coding RNA BCAR4 promotes liver cancer progression by regulating proliferation, migration and invasionOncology Letters 2020; 20(3): 2779 doi: 10.3892/ol.2020.11826
67
Monica Valente, Alessia Covre, Anna Maria Di Giacomo, Michele Maio. Hepato-Pancreato-Biliary Malignancies2021; : 1 doi: 10.1007/978-3-030-37482-2_50-1
68
Kurt Sartorius, Ping An, Cheryl Winkler, Anil Chuturgoon, Xiaodong Li, Julia Makarova, Anna Kramvis. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA DysregulationFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.661204
69
Ting Zhang, Linglin Zhao, Shengyuan Zeng, Lu Bai, Junxia Chen, Zheng Zhang, Yalan Wang, Changzhu Duan. UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cellsInternational Journal of Molecular Medicine 2017; 39(1): 126 doi: 10.3892/ijmm.2016.2805
70
Yao Liu, Ying Feng, Yuxin Li, Ying Hu, Qun Zhang, Yunyi Huang, Ke Shi, Chongping Ran, Jie Hou, Guiqin Zhou, Xianbo Wang. Chlorogenic Acid Decreases Malignant Characteristics of Hepatocellular Carcinoma Cells by Inhibiting DNMT1 ExpressionFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00867
71
Parvin Zamani, Maryam Matbou Riahi, Amir Abbas Momtazi-Borojeni, Khadijeh Jamialahmadi. Gankyrin: a novel promising therapeutic target for hepatocellular carcinomaArtificial Cells, Nanomedicine, and Biotechnology 2018; 46(7): 1301 doi: 10.1080/21691401.2017.1388250
72
Angela Cozma, Adriana Fodor, Romana Vulturar, Adela-Viviana Sitar-Tăut, Olga Hilda Orăşan, Flaviu Mureşan, Cezar Login, Ramona Suharoschi. DNA Methylation and Micro-RNAs: The Most Recent and Relevant Biomarkers in the Early Diagnosis of Hepatocellular CarcinomaMedicina 2019; 55(9): 607 doi: 10.3390/medicina55090607
73
Zhifei Lin, Huliang Jia, Liang Hong, Yahui Zheng, Weiqin Shao, Xudong Ren, Wenwei Zhu, Lu Lu, Ming Lu, Jubo Zhang, Jinhong Chen. Prognostic impact of SET domain‑containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resectionOncology Letters 2018;  doi: 10.3892/ol.2018.9083
74
Patrick Wellington da Silva dos Santos, Ana Rita Thomazela Machado, Rone Aparecido De Grandis, Diego Luis Ribeiro, Katiuska Tuttis, Marco Morselli, Alexandre Ferro Aissa, Matteo Pellegrini, Lusânia Maria Greggi Antunes. Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cellsFood and Chemical Toxicology 2020; 136: 111047 doi: 10.1016/j.fct.2019.111047
75
Volkan Ince, Tevfik Tolga Sahin, Sami Akbulut, Sezai Yilmaz. Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteriaWorld Journal of Clinical Cases 2022; 10(29): 10413-10427 doi: 10.12998/wjcc.v10.i29.10413
76
Ting Lin, Jingxian Gu, Kai Qu, Xing Zhang, Xiaohua Ma, Runchen Miao, Xiaohong Xiang, Yunong Fu, Wenquan Niu, Junjun She, Chang Liu. A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients’ prognosisAging 2018; 10(9): 2480 doi: 10.18632/aging.101563
77
Jiansong Wu, Qiang Niu, Jie Yuan, Xiaodan Xu, Liuxia Cao. lncRNA‑CD160 decreases the immunity of CD8+ T cells through epigenetic mechanisms in hepatitis B virus infectionOncology Letters 2020;  doi: 10.3892/ol.2020.11534